Characteristics of lymph node metastasis in non-small cell lung cancer underwent thoracoscopic lobectomy and lymphadenectomy

  • Lê Hải Sơn Bệnh viện Trung ương Quân đội 108
  • Trần Trọng Kiểm Bệnh viện Trung ương Quân đội 108
  • Mai Văn Viện Bệnh viện Trung ương Quân đội 108
  • Ngô Vi Hải Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Non-small cell lung cancer, thoracoscopic lobectomy, lymph node metastases, lymph node resection

Abstract

Objective: To find out some characteristics of lymph node metastasis in non-small cell lung cancer patients. Subject and method: Eighty patients who had undergone thoracoscopic lobectomy and lymph node resection from July 2017 to July 2019. Statistics of primary tumor lesions and lymph node metastases in thirsty patients who had lymph node metastasis. Analyze the relations between the tumor characteristics and lymph node metastases. Result: The patients with lymph node metastasis was identified in 32 (38.1%); the rate of N1 metastasis was 14.3%, N1 and N2 stage metastasis was 8.3%, and skip metastasis was 15.5%. The rate of lymph node metastasis by tumor size: Tumor < 3cm 25.9%, tumor > 3cm and < 5cm 59.3%, tumor > 5cm and < 7cm 66.7%. The rate of metastasis by invasive lesion: Non-invasion 36.8%, visceral pleura invasion 43.5%, parietal pleura invasion 25.0%. Conclusion: Lymph node metastasis in non-small cell lung cancer was accounted for a high proportion; lymph node metastasis properties were associated with primary tumor size

Article Details

References

1. Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians 68(6): 394-424.
2. Seok Y et al (2014) Frequency of lymph node metastasis according to the size of tumors in resected pulmonary adenocarcinoma with a size of 30 mm or smaller. Journal of Thoracic Oncology 9(6): 818-824.
3. Moulla Y et al (2019) Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: A case control study. Journal of cardiothoracic surgery 14(1): 11.
4. Detterbeck FC et al (2017) The eighth edition lung cancer stage classification. Chest 151(1): 193-203.
5. Haruki T et al (2015) Mediastinal nodal involvement in patients with clinical stage I non–small-cell lung cancer: Possibility of rational lymph node dissection. Journal of Thoracic Oncology 10(6): 930-936.
6. Bao F et (2014) Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer. Journal of thoracic disease 6(12): 1697.
7. Zhao JL et al (2019) Selective lymph node dissection for clinical T1 stage non-small cell lung cancer. Translational Cancer Research 8(8): 2820-2828.
8. Lê Hải Sơn, Trần Trọng Kiểm, Mai Văn Viện (2018) Nhận xét bước đầu đặc điểm tổn thương trong mổ của u và hạch ở bệnh nhân ung thư phổi không tế bào nhỏ được phẫu thuật nội soi tại Bệnh viện Trung ương Quân đội 108. Tạp chí Y Dược lâm sàng 108, tập 13: tr. 136-140.
9. Shimizu K et al (2005) Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. The Journal of thoracic cardiovascular surgery 130(1): 160-165.
10. Shafazand S and M.K.J.J.o.T.O. Gould (2006) A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. Journal of Thoracic Oncology 1(9): 953-959.
11. Suzuki K et al (1999) Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. The Journal of Thoracic Cardiovascular Surgery 117(3): 593-598.